Mo1806 ANTI TNF MEDICATIONS BUT NOT JAK INHIBITORS ARE ASSOCIATED WITH INCREASED RISK OF VENOUS THROMBOEMBOLISM. DATA FROM A LARGE NATIONAL COHORT. IS IT THE MECHANISM OF THE DRUG OR THE DISEASE? — Omair Iqbal (2024) | RDL Network
Mo1806 ANTI TNF MEDICATIONS BUT NOT JAK INHIBITORS ARE ASSOCIATED WITH INCREASED RISK OF VENOUS THROMBOEMBOLISM. DATA FROM A LARGE NATIONAL COHORT. IS IT THE MECHANISM OF THE DRUG OR THE DISEASE?
Simon Chan, Ye Chen, Kevin Casey, Ola Olén, Jonas F. Ludvigsson, Franck Carbonnel, Bas Oldenburg, Marc J. Gunter, Anne Tjønneland, Olof Grip, Pilar Amian, Aurelio Barricarte, Manuela M. Bergmann, Marie‐Christine Boutron‐Ruault, Amanda J. Cross, Andrew Hart, Rudolf Kaaks, T J Key, María Dolores Chirlaque López, Giovanna Masala, Jonas Manjer, Anja Olsen, Kim Overvad, Domenico Palli, Elio Riboli, María‐José Sánchez, Rosario Tumino, Roel Vermeulen, W. M. Monique Verschuren, Nicholas J. Wareham, Ashwin N. Ananthakrishnan, Kristin E. Burke, Emily W. Lopes, James M. Richter, Paul Lochhead, Andrew T. Chan, A. Wolk, Hamed Khalili
Discussion(0)
No comments yet. Be the first to comment.